Developed through a multi-phase process involving Delphi rounds and a nominal group consensus conference, the PRINTO framework introduces updated categories: systemic JIA, RF-positive JIA, enthesitis/spondylitis-related JIA, early-onset ANA-positive JIA, and other JIA. This evidence concerns the gene BTG3 and spondylitis.